Investments

NovaSignal is a medical technology and data company that is revolutionizing transcranial Doppler ultrasound through the application of robotics, artificial intelligence, and cloud computing. The NovaSignal Platform, including the FDA cleared NovaGuide 2 Intelligent Ultrasound and cloud-based NovaGuide View, assesses cerebral hemodynamics in real time to support physicians in their clinical decision making.

DispatchHealth provides on-demand home health care services, from emergency care to   a 30-day alternative to a hospital stay, all delivered straight to the patient’s home. With a growing elderly population and increasing opportunities to treat acute and chronic illnesses at home, DispatchHealth reduces global healthcare costs by providing home healthcare services that reduce over-utilization of emergency care and increase patient convenience.

AliveCor was founded on the strength of our proprietary technologies: AI-enabled, machine learning-powered ECG sensors that deliver medical-grade heart data anytime, anywhere. Our digital tools help patients access, manage and share their data, and connect with cardiologists to better understand and manage their heart health.

Founded in 2014, NOTA Laboratories is focused on developing NO delivery platform technologies that have broad applicability in advancing the treatment for many debilitating and potentially life-threatening conditions and diseases, including Sars CoV-2 (COVID-19), the seasonal flu, the common cold, systemic inflammatory response syndrome (SIRS), chronic rhinosinusitis (CRS), Chronic Obstructive Pulmonary Disease (COPD), persistent pulmonary hypertension of the newborn (PPHN), and catheter related bloodstream infection (CRBSI).

Developer of an innovative health-tech platform designed to capture data from vital senses and make it useful at all touch points of patient care. The company's platform uses smart textile technologies to convert subjectively measured sensory receptor data into 4-dimensional visualization and algorithmic data. By applying artificial intelligence and machine learning, they augment sensory information, helping users reduce negative health impacts in hospitals, skilled nursing facilities, and in-home care.

neoplas med GmbH was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology e. V. (INP) in Greifswald, Germany. Based on the INP research into plasma medicine, the emerging company develops innovative products for medical applications. The first product developed on this basis is the CE-marked kINPen® MED atmospheric pressure plasmajet, the first internationally approved and marketed plasma jet for the treatment of chronic wounds and pathogen-induced skin disorders. It is the result of a long-lasting cooperation with the INP institute, the university hospital of Greifswald, Germany, the Charité hospital of Berlin, Germany, and various industrial partners.

We have reimagined ultrasound as a simple and effective delivery platform, capable of delivering a broad-range of therapeutics in a formulation-independent manner. This enables us to push virtually any therapeutic class, including temperamental molecules, like nucleic acids, directly into cells with astounding efficacy and accuracy, affecting historically "undruggable" targets.

Emerge is a cross-reality presence company, building a platform that aims to enable more meaningful, engaging, and diverse interactions in XR that bring us closer to the people we care about. Emerge is creating a future where distance and time don’t stand in the way of feeling present with a first product that enables users to interact, share and physically feel XR immersive content with bare hands.

NExT-eS is a next-generation battery management system. The system offered by the company allows for the easy reuse of second-hand lithium-ion batteries, which are becoming more commonly available thanks to the spread of electric vehicles, and also provides a battery monitoring service. Through the creation of a practical next-generation BMS that reduces system loss, the company aims to contribute to safety and reliability improvements in industrial lithium-ion battery systems, which are in high demand throughout the world. In particular, it hopes to contribute to the spread of new electric vehicles (NEVs) in China, the world's largest automotive market, and the spread of electric forklifts and autonomous carriers (AGVs) in the European Market.

Uhuru’s corporate philosophy is to “Create a sustainable society with technology and out of the box thinking”. We aspire to contribute to our clients and society by bringing added value with innovative products and services based on the Internet. Focusing on IoT business, we continue to bring about transformation at our clients with enebular, our IoT orchestration service that allows unified management of edge devices and the cloud. Our teams of experts in consulting, engineering and creative production strive to create businesses at our clients by offering one-stop access to professional services in business strategy, technological support, and communication strategy.

Nanoramic—rebranded from FastCAP in 2018—is an industry-leading energy storage technology and materials solution innovator headquartered in Boston, MA. Based on a deep knowledge of nanocarbon materials, processes, and applications, Nanoramic has demonstrated success in ultracapacitors, polymer-based composites, thermal interface materials, and binderless electrodes for energy storage.

RIOS is a technology company that helps global customers automate their factory assembly lines, warehouses, and supply chain operations by deploying AI-powered robotic workcells. RIOS offers factory automation as a service and brings lights-out factories to the manufacturing, consumer packaged goods, and food & beverage sectors.

Spirosure is a California-based company working to develop innovative medical devices that ensure patients with chronic respiratory illness have access to effective, non-invasive, and easy to use tools to diagnose and manage their disease while living happy, full lives.

The Company recently launched FenomPRO®, an easy-to-use device that measures Fractional Exhaled Nitric Oxide (FeNO). FeNO measurement can be used to diagnose asthma, to detect nonadherence to inhaled corticosteroids (ICS), to be an early sign of worsening asthmatic inflammation and to manage difficult-to-control asthma because an elevated FeNO level can be predictive of a good response to ICS.

The product is intended to be used in the clinic setting and is currently available in the United States, the EU and India.

As of June 2020, Spirosure is operating as a division of CAIRE Inc. known as CAIRE Diagnostics Inc. CAIRE became a part of the Niterra Group in December 2018, to establish a global foothold in the respiratory therapy market.

The next generation in lighting has arrived, shining brighter and farther than ever before. In the last decade, LED enabled a new generation of lighting that changed everything. Now, LaserLight outshines the limits of LED to deliver safe, high luminance white light from an incredibly small point source. LaserLight doesn’t just offer superior technology, it’s enabling entirely new opportunities. We are commercializing revolutionary semi-polar GaN LaserLight for the next generation of display, automotive, and specialty applications. LaserLight sources are used directly in single color and R-G-B applications, or integrated into laser pumped phosphor architectures.